期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

依折麦布治疗动脉粥样硬化性心血管疾病的研究进展 被引量：10

原文传递
导出
摘要 动脉粥样硬化是动脉壁的慢性非感染性炎症反应，动脉粥样硬化引起的心脑血管疾病是发达国家人群的主要死亡原因之一。随着我国人民生活水平的提高和饮食结构的改变，该病亦成为我国居民的主要死亡原因。
作者 铁春苗 张娜 高康璐 谢小洁
机构地区 浙江大学医学院附属第二医院心内科
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2015年第7期646-649,共4页 Chinese Journal of Cardiology
基金 国家自然科学基金（31171392,31371475）
关键词 动脉粥样硬化性心血管疾病 依折麦布 主要死亡原因 治疗 心脑血管疾病 炎症反应 非感染性 发达国家
分类号 R543.5 [医药卫生—心血管疾病]
  • 相关文献

参考文献32

  • 12014年中国胆固醇教育计划血脂异常防治专家建议[J].中华心血管病杂志,2014,42(8):633-636. 被引量：154
  • 2Jia L, Betters JL, Yu L. Niemann-piek Cl-like 1 ( NPC1LI ) protein in intestinal and hepatic cholesterol transport [ J ]. Annu Rev Physiol, 2011, 73: 239-259.
  • 3Zambrano T, Saavedra N, Lanas F, et al. Efficacy of ezetimibe is not related to NPC1L1 gene polymorphisms in a pilot study of Chilean hypercholesterolemic subjects [ J ]. Mol Diagn Tber, 2015,19( 1 ) :45-52.
  • 4Hegele RA, Guy J, Ban MR, et al. NPCIL1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe[ J]. Lipids Health Dis,2005,4: 16.
  • 5Sudhop T, Liitjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans [ J ]. Circulation, 2002,106( 15 ) : 1943-1948.
  • 6Oswald S, Knig J, Ltitjohann D, et al. Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1 [J] . Pharmacogenet Genomics, 2008,18 (7) : 559- 568.
  • 7Patrick JE, Kosoglon T, Stauber KL, et al. Disposition of the selective cholesterol absorption inhibitor ezetimibe in healthy male subjects [ J ]. Drug Metab Dispos,2002, 30 (4) : 430-437.
  • 8Getz GS, Reardon CA. Animal models of atheroscterosis [ J]. Arterioseler Thromb Vase Biol, 2012,32 ( 5 ) : 1104-1115.
  • 9Davidson WS, Silva RA, Chantepie S, et al. Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function [J]. Arterioscler Thromb Vase Biol, 2009,29 (6) : 870-876.
  • 10Boean TM, MueBer SB, Mazur MJ, et ah The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotie lesion formation [ J ]. Atheroselerosis, 1993,102( 1 ) : 9-22.

二级参考文献9

  • 1中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南.中华心血管病杂志,2001,29:315-317.
  • 2Stone NJ,Robinson J,Lichtenstein AH,et al.2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults:a report of the American College of Cardiology/American Heart Association task force on practice guidelines[J].Circulation,2013,pii:S0735-1097 (13)06028-2.
  • 3Scandinavian simvastatin survival study group.Randomised trial of lowering in 4444 patients with coronary heart disease:the Scandinavian simvastatin survival study (4S)[J].Lancet,1994,344:1383-1389.
  • 4Sharp collaborative group.Study of heart and renal protection (SHARP):randomized trial to assess the effects of lowering lowdensity lipoprotein cholesterol among 9438 patients with chronic kidney disease[J].Am Heart J,2010,160:785-794.e10.
  • 5Baigent C,Blackwell L,Emberson J,et al.Efficacy and safety of more intensive lowering of LDL cholesterol:a meta-analysis of data from 170000 participants in 26 randomised trials[J].Lancet,2010,376:1670-1681.
  • 6FDA Drug Safety Communication:New restrictions,contraindications,and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury[EB/OL].(2011-06-08)[2014-03-27].http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm.
  • 7The National Lipid Association recommendations for patientcentered treatment of dyslipidemia[EB/OL].(2014-05-20)[2014-05-21].https://www.lipid.org/nla/recommendationspatient-centered-management-dyslipidemia.
  • 8Cannon CP,Braunwald E,McCabe CH,et al.Intensive versus moderate lipid lowering with statins after acute coronary syndromes[J].N Engl J Med,2004,350:1495-1504.
  • 9HPS2-THRIVE Collaborative Group.HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant:trial design,pre-specified muscle and liver outcomes,and reasons for stopping study treatment[J].Eur Heart J,2013,34:1279-1291.

共引文献153

同被引文献67

引证文献10

二级引证文献43

中华心血管病杂志
2015年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部